Daniel Mueller
Impact in
- Biological Psychiatry top 0.2%
- Tryptophan and brain disorders
- Pharmacology top 0.05%
- Pharmacogenetics and Drug Metabolism
- Treatment of Major Depression
Papers in
-
- Schizophrenia research and treatment 51
- Bipolar Disorder and Treatment 29
- Pharmacology 60
- Pharmacogenetics and Drug Metabolism 59
- Treatment of Major Depression 46
- Co-authors
- James L. Kennedy (98 shared papers)Arun Kumar Tiwari (67 shared papers)Clement C.H. Zai (53 shared papers)Jeffrey Alan Lieberman (44 shared papers)Herbert Y. Meltzer (46 shared papers)Chad Bousman (22 shared papers)Vincenzo De Luca (23 shared papers)Sidney H. Kennedy (45 shared papers)
- Journals
- Pharmacogenomics (20 papers)The World Journal of Biological Psychiatry (13 papers)Pharmacopsychiatry (10 papers)Clinical Pharmacology & Therapeutics (10 papers)The Canadian Journal of Psychiatry (9 papers)
- Partner nations
- CanadaUnited StatesGermany
In The Last Decade
Daniel Mueller
377 papers receiving 12.6k citations
Daniel Mueller's Hit Papers
Peers
Comparison fields: 5 of 185
- Biological Psychiatry 1.0k
- Pharmacology 2.1k
- Psychiatry and Mental health 3.0k
- Pharmacology 1.6k
- Behavioral Neuroscience 301
Countries citing papers authored by Daniel Mueller
This map shows the geographic impact of Daniel Mueller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Mueller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Mueller more than expected).
Fields of papers citing papers by Daniel Mueller
This network shows the impact of papers produced by Daniel Mueller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Mueller. The network helps show where Daniel Mueller may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Mueller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 396 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder Hit paper breakdown → | 2016 | 872 |
| 2 | COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study Hit paper breakdown → | 2020 | 443 |
| 3 | Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process Hit paper breakdown → | 2014 | 356 |
| 4 | Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 , OPRM1 , and COMT Genotypes and Select Opioid Therapy Hit paper breakdown → | 2021 | 301 |
| 5 | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 , CYP2C19 , CYP2B6 , SLC6A4 , and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants Hit paper breakdown → | 2023 | 253 |
| 6 | 2007 | 233 | |
| 7 | 2018 | 227 | |
| 8 | An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels Hit paper breakdown → | 2021 | 214 |
| 9 | 2017 | 177 | |
| 10 | 2019 | 166 | |
| 11 | 2015 | 163 | |
| 12 | Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes Hit paper breakdown → | 2024 | 153 |
| 13 | 2018 | 152 | |
| 14 | 2022 | 140 | |
| 15 | 2000 | 136 | |
| 16 | 2020 | 135 | |
| 17 | 2016 | 125 | |
| 18 | 2006 | 117 | |
| 19 | 1987 | 106 | |
| 20 | 2021 | 106 |
About Daniel Mueller
Daniel Mueller is a scholar working on Psychiatry and Mental health, Pharmacology, Biological Psychiatry, Pharmacology and Cognitive Neuroscience, having authored 396 papers that have together received 13.0k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (59 papers), Schizophrenia research and treatment (51 papers), Treatment of Major Depression (46 papers), Tryptophan and brain disorders (37 papers), Bipolar Disorder and Treatment (29 papers), Diet and metabolism studies (25 papers), Functional Brain Connectivity Studies (23 papers) and Neurotransmitter Receptor Influence on Behavior (21 papers). The work is most often cited by research in Biological Psychiatry (1.0k citations), Pharmacology (2.1k citations), Psychiatry and Mental health (3.0k citations), Pharmacology (1.6k citations) and Behavioral Neuroscience (301 citations). Daniel Mueller has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include James L. Kennedy, Arun Kumar Tiwari, Clement C.H. Zai, Jeffrey Alan Lieberman, Herbert Y. Meltzer, Chad Bousman, Vincenzo De Luca, Sidney H. Kennedy, Eva J. Brandl and Roumen V. Milev. Their work appears in journals such as Pharmacogenomics, The World Journal of Biological Psychiatry, Pharmacopsychiatry, Clinical Pharmacology & Therapeutics and The Canadian Journal of Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.